APUS News
Archived Headlines
- US IPO Week Ahead: Medical device maker lines up the first sizable March IPO 02/28/25
- US IPO Week Ahead: Small IPOs tentatively scheduled for the short holiday week 02/14/25
- Inflammation biotech Apimeds Pharmaceuticals ups deal size by 74% ahead of $20 million IPO 01/29/25
- Inflammation-focused biotech Apimeds Pharmaceuticals sets terms for $12 million IPO 11/08/24
- Inflammation-focused biotech Apimeds Pharmaceuticals US files for a $12 million IPO 09/25/24
US IPO Weekly Recap: Sizable insurance IPOs deliver solid trading
A few new issuers went public this past week, joined by two SPACs. Bermuda-based Aspen Insurance (AHL) upsized its share offering and priced at the midpoint to raise $398 million at a $2.8 billion market cap. Aspen is a specialty (re)insurer with a diverse...read more
Inflammation drug developer Apimeds Pharmaceuticals US prices IPO at $4.00, the low end of the range
Apimeds Pharmaceuticals US, a clinical-stage developer of bee venom-based treatments for inflammation, raised $14 million by offering 3.4 million shares at $4.00, the low end of the range of $4.00 to $5.00. The company downsized the offering from a...read more
US IPO Week Ahead: 2 sizable insurers set to take on the IPO market
A handful of IPOs are scheduled to price in the week ahead, led by two sizable insurers. Bermuda-based Aspen Insurance (AHL) plans to raise $330 million at a $2.8 billion market cap. Aspen Insurance Holdings is a specialty (re)insurer with a diverse product...read more
US IPO Week Ahead: Small IPOs may list amid market volatility
...read more